Close
ACHEMA MIDDLE EAST 2026

Sharp launches Clinventory Inventory Management System (IMS) for clinical trials

AI Summary

Sharp – part of UDG Healthcare plc, a global leader in contract packaging clinical supply services, has launched a new Inventory Management System (IMS) to support clinical trial sponsors in managing inventory and supplies.

The new system – named Clinventory – has been designed to provide full visibility of stock levels at investigator sites and tracking product through the supply chain. It ensures that sponsors have a comprehensive, real-time view of their trial.

Using the Clinventory IMS will also create efficiencies for trial sponsors by improving the drug management process by leveraging automation to increase reliability, while reducing the costs associated with manual processes.

Sascha Sonnenberg, Global Head of Business Development at Sharp Clinical said “At Sharp, we are always exploring ways to support our clients’ efforts to create more efficiency and lower the cost of their clinical trials.

“Clinventory has been designed specifically with those smaller-volume, early stage or open label clinical trials in mind, where a larger, more expensive inventory system might offer an array of functionality that is surplus to needs”.

Key features of the Clinventory IMS include:

  • On-demand study supply information
  • Eliminates the need for manual processes for dispatches and returns
  • Customisable automatic resupply, which can be updated as the study enrolment increases or decreases
  • Temperature excursion tracking with supply release and approval
  • Manual shipment requests for emergency situations.

The system complements Sharp’s Clinteract Interactive Response Technology (IRT) solution, which delivers all the features of Clinventory IMS plus subject enrolment and trial randomisation functionality.

The availability of Clinventory IMS means the company’s clients now have a choice of trial management solutions appropriate to the scale of their trial.

Senior pharmaceutical decision - makers don’t consume every piece of content. They have sources they trust. Pharma Advancement is one of them.

Reaching this audience means appearing where they already are — inside trusted editorial that covers the full pharmaceutical and life sciences value chain. Our 2026 Media Pack shows you where to be seen:

Magazine & Digital

Where pharmaceutical decision - makers go to understand what’s coming next. Your brand belongs in that conversation.

Insights & Reports

The analysis and research the sector references when it matters most. Being part of it positions you differently.

Brand Authority

The companies that show up consistently in trusted editorial don’t need to explain who they are. They already are.

SUBSCRIBE OUR NEWSLETTER

WHITE PAPERS

RELATED ARTICLES